Published in J Pharmacol Exp Ther on August 01, 1999
Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci U S A (2006) 1.95
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol (1999) 1.65
Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J Clin Invest (2001) 1.45
Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. J Neurochem (2003) 1.33
Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut (2001) 1.29
Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. Neurosurgery (2005) 1.24
COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice. J Clin Invest (2009) 1.18
A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors. Biochem J (2001) 1.14
Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo. Mol Cancer (2006) 1.03
Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol (2001) 1.03
Gastrointestinal damage induced by celecoxib and rofecoxib in rats. Dig Dis Sci (2001) 1.02
COX-2 and cancer: a new approach to an old problem. Br J Pharmacol (2001) 1.02
Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. Br J Pharmacol (2005) 0.99
Cyclooxygenase-2 in epilepsy. Epilepsia (2013) 0.98
Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation. Br J Pharmacol (2002) 0.98
Accelerated fracture healing in mice lacking the 5-lipoxygenase gene. Acta Orthop (2010) 0.96
Do NSAIDs affect the progression of osteoarthritis? Inflammation (2002) 0.95
Oral valdecoxib and injected parecoxib for acute postoperative pain: a quantitative systematic review. BMC Anesthesiol (2003) 0.89
LC-MS/MS confirms that COX-1 drives vascular prostacyclin whilst gene expression pattern reveals non-vascular sites of COX-2 expression. PLoS One (2013) 0.88
Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database. Eur J Clin Pharmacol (2004) 0.87
Detergents profoundly affect inhibitor potencies against both cyclo-oxygenase isoforms. Biochem J (2004) 0.86
Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. Br J Pharmacol (2002) 0.86
Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats. Br J Pharmacol (2008) 0.86
Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain. Biochem J (2005) 0.84
COX-1 vs. COX-2 as a determinant of basal tone in the internal anal sphincter. Am J Physiol Gastrointest Liver Physiol (2008) 0.84
Neuromodulatory role of endogenous interleukin-1β in acute seizures: possible contribution of cyclooxygenase-2. Neurobiol Dis (2011) 0.84
Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences? Naunyn Schmiedebergs Arch Pharmacol (2006) 0.83
Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.82
COX-2 expression and function in the hyperalgesic response to paw inflammation in mice. Prostaglandins Leukot Essent Fatty Acids (2008) 0.82
Inhibitory effect of cyclo-oxygenase-2 inhibitor on the production of matrix metalloproteinases in rheumatoid fibroblast-like synoviocytes. Rheumatol Int (2003) 0.81
Arachidonic acid metabolites follow the preferential course of cyclooxygenase pathway for the basal tone in the internal anal sphincter. Am J Physiol Gastrointest Liver Physiol (2009) 0.81
Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisition. Epilepsia (2011) 0.81
Inhibition of prostaglandin F(2alpha) by selective cyclooxygenase 2 inhibitors accounts for reduced rat leukocyte migration. Inflammation (2005) 0.81
Prostaglandin H2 synthase-1 and -2 expression in guinea pig gestational tissues during late pregnancy and parturition. J Physiol (2005) 0.81
Nature of extracellular signal that triggers RhoA/ROCK activation for the basal internal anal sphincter tone in humans. Am J Physiol Gastrointest Liver Physiol (2015) 0.80
Cyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold. J Med Chem (2012) 0.79
Cyclooxygenase-2 inhibitors: promise or peril? Mediators Inflamm (2002) 0.79
A Novel Selective Prostaglandin E2 Synthesis Inhibitor Relieves Pyrexia and Chronic Inflammation in Rats. Inflammation (2016) 0.78
PET imaging of cyclooxygenase-2 (COX-2) in a pre-clinical colorectal cancer model. EJNMMI Res (2016) 0.77
Effect of the COX-2 selective inhibitor l-745,337 on inflammation and organ prostaglandin E2 (PGE2) levels in adjuvant arthritic rats. Inflammation (2000) 0.77
Effects of soy diet on inflammation-induced primary and secondary hyperalgesia in rat. Eur J Pain (2010) 0.77
New dogmas or old? Gut (2003) 0.76
Comparative study of anti-inflammatory and ulcerogenic activities of different cyclo-oxygenase inhibitors. Inflammopharmacology (2005) 0.76
Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits. PLoS One (2014) 0.76
Substance P, opioid, and catecholamine systems in the mouse central nervous system (CNS). Proc Natl Acad Sci U S A (2002) 0.76
Marine Diterpenoids as Potential Anti-Inflammatory Agents. Mediators Inflamm (2015) 0.75
Low direct cytotoxicity of nabumetone on gastric mucosal cells. Dig Dis Sci (2005) 0.75
Molecular Mechanism for Various Pharmacological Activities of NSAIDS. Pharmaceuticals (Basel) (2010) 0.75
On the functionalization of benzo[e][2,1]thiazine. Beilstein J Org Chem (2009) 0.75
Comparative effects of the ω3 polyunsaturated fatty acid derivatives resolvins E1 and D1 and protectin DX in models of inflammation and pain. J Inflamm Res (2017) 0.75
Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature (1980) 9.25
Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science (1999) 7.84
Algebraic reconstruction techniques (ART) for three-dimensional electron microscopy and x-ray photography. J Theor Biol (1970) 6.86
Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med (2001) 6.67
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features. Ann Intern Med (1984) 6.54
Inhibition of nuclear protein import by nonhydrolyzable analogues of GTP and identification of the small GTPase Ran/TC4 as an essential transport factor. J Cell Biol (1993) 6.47
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst (1996) 5.28
U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol (2002) 4.92
Income inequality, primary care, and health indicators. J Fam Pract (1999) 4.54
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci (1999) 4.35
History of the enzyme nomenclature system. Bioinformatics (2000) 3.90
Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet (1993) 3.72
A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med (1998) 3.62
Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature (1999) 3.57
UK guidelines for the management of cutaneous melanoma. Br J Plast Surg (2002) 3.51
beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell (1995) 3.33
Mycotoxins (ochratoxin A, citrinin, and sterigmatocystin) and toxigenic fungi in grains and other agricultural products. J Agric Food Chem (1973) 3.21
Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem (1997) 3.20
A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01
Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem (2000) 2.89
Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res (1995) 2.74
The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med (1998) 2.73
Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature (2000) 2.73
Different training procedures recruit either one or two critical periods for contextual memory consolidation, each of which requires protein synthesis and PKA. Learn Mem (1999) 2.72
Patient knowledge of anaesthesia and peri-operative care. Anaesthesia (1994) 2.61
Loss of transcriptional silencing causes sterility in old mother cells of S. cerevisiae. Cell (1996) 2.53
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49
Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. Br J Ophthalmol (1994) 2.47
Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation (1998) 2.46
Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett (1993) 2.41
Outcome of pregnancy in a woman with an increased body mass index. BJOG (2005) 2.38
Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res (1996) 2.37
Views of junior doctors about their work: survey of qualifiers of 1993 and 1996 from United Kingdom medical schools. Med Educ (2000) 2.29
Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med (1993) 2.29
The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol (1984) 2.25
Identification and isolation of a membrane protein necessary for leukotriene production. Nature (1990) 2.20
Health-related quality-of-life results from multinational clinical trials of insulin lispro. Assessing benefits of a new diabetes therapy. Diabetes Care (1997) 2.19
Clinical predictors of admission in infants with acute bronchiolitis. Arch Dis Child (2011) 2.18
Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med (1997) 2.17
Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer. Dig Surg (2005) 2.16
MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J Biol Chem (1990) 2.14
Leukotriene B: a potential mediator of inflammation. J Pharm Pharmacol (1980) 2.13
The ecological validity of tests of executive function. J Int Neuropsychol Soc (1998) 2.12
Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas. Arch Pathol Lab Med (1998) 2.11
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10
Cloning of the cDNA for human 5-lipoxygenase. Proc Natl Acad Sci U S A (1988) 2.06
Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res (2000) 2.04
Self-efficacy and health behavior among older adults. J Health Soc Behav (1993) 2.04
Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell (1996) 2.04
Early and late complications after pancreatic necrosectomy. Surgery (2005) 2.03
The impact of maternal depression in pregnancy on early child development. BJOG (2008) 2.02
Discovery of a receptor related to the galanin receptors. FEBS Lett (1999) 2.01
BD8 certification of visually impaired people. Br J Ophthalmol (1998) 1.96
5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J Exp Med (1993) 1.95
Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry (1993) 1.93
Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology (1996) 1.92
Retirement intentions of doctors who qualified in the United Kingdom in 1974: postal questionnaire survey. J Public Health Med (2001) 1.92
Micromethods for induction and assay of mouse mixed lymphocyte reactions and cytotoxicity. Eur J Immunol (1976) 1.90
Beta-lactamase of R factors. J Bacteriol (1968) 1.89
L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol (1989) 1.88
Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience (1999) 1.88
Fine-needle aspiration cytology guided by endoscopic ultrasonography: results in 141 patients. Endoscopy (1995) 1.87
Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology (1998) 1.84
Mutation of the gene encoding cellular retinaldehyde-binding protein in autosomal recessive retinitis pigmentosa. Nat Genet (1997) 1.84
Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Res (2000) 1.83
p-Chlorophenylalanine-induced chemical manifestations of phenylketonuria in rats. Science (1967) 1.82
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer. Ann Oncol (2012) 1.82
Care for depression in HMO patients aged 65 and older. J Am Geriatr Soc (2000) 1.82
No substitute for the intravenous route. Anesthesiology (2001) 1.82
Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex Transm Infect (2002) 1.81
Platelet-derived growth factor. Specific binding to target cells. J Biol Chem (1982) 1.80
BICAV: a block-iterative parallel algorithm for sparse systems with pixel-related weighting. IEEE Trans Med Imaging (2001) 1.79
Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension. Pediatrics (2001) 1.78
Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology (2003) 1.78
Environmental indicators: a tool for evaluating community-based health-promotion programs. Am J Prev Med (1993) 1.76
Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol Cell (1999) 1.74
5-Lipoxygenase. Annu Rev Biochem (1994) 1.73
Patients' choices and perceptions after an invitation to participate in treatment decisions. Soc Sci Med (1992) 1.72
Common structural features of MAPEG -- a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Sci (1999) 1.70
Text entry on handheld computers by older users. Ergonomics (2000) 1.69
Principles for the management of penetrating cardiac wounds. Ann Surg (1979) 1.69
An examination of verbal working memory capacity in children with specific language impairment. J Speech Lang Hear Res (1999) 1.69
Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J Biol Chem (1988) 1.68
CT in patients with scirrhous carcinoma of the GI tract: imaging findings and value for tumor detection and staging. AJR Am J Roentgenol (1995) 1.68
Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide. Proc Natl Acad Sci U S A (2001) 1.68
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther (2001) 1.65